Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1999;8(4-5):245–251. doi: 10.1080/09629359990414

Interrelationship of the kinin system, nitric oxide and eicosanoids in the antigen-induced arthritis in rabbits.

F A Palácios 1, G S Novaes 1, M L Guzzo 1, I M Laurindo 1, S B de Mello 1
PMCID: PMC1781805  PMID: 10704079

Abstract

The aim of the present study was to investigate the interrelationship of the kinin system, nitric oxide and eicosanoids in the acute phase of antigen-induced arthritis (AIA) in rabbits. The arthritis was induced in immunized rabbits and the following parameters were evaluated 24 hours later: leukocyte influx (total and differential white cell count), vascular permeability (Evans's blue method), and synovial PMN cell infiltrate. PGE2 and LTB4 (radioimmunoassay) levels were quantified in the synovial fluid. The animals were pre-treated with 20mg/kg/day during 14 days with L-NAME or D-NAME and/or Enalapril (0.12 mg/kg/day-14 days), and/or the B2 antagonist of Bradykinin HOE 140 (0.9 mg/kg). Our results showed that L-NAME was effective in the prevention of AIA with reduction of all Inflammatory parameters analyzed. Enalapril partially reverted the L-NAME anti-inflammatory effects. The simultaneous treatment with HOE 140 abolished this reversion and returned the inflammatory parameters to the levels observed in L-NAME treated animals. Our results suggest that pressoric alterations induced by L-NAME could not account for all its anti-inflammatory action in this model of experimental arthritis. Additionally the contribution of the kinin system in AIA was characterized as well as its interaction with eicosanoids and nitric oxide.

Full Text

The Full Text of this article is available as a PDF (226.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beasley D., Eldridge M. Interleukin-1 beta and tumor necrosis factor-alpha synergistically induce NO synthase in rat vascular smooth muscle cells. Am J Physiol. 1994 Apr;266(4 Pt 2):R1197–R1203. doi: 10.1152/ajpregu.1994.266.4.R1197. [DOI] [PubMed] [Google Scholar]
  2. Belenky S. N., Robbins R. A., Rennard S. I., Gossman G. L., Nelson K. J., Rubinstein I. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro. J Lab Clin Med. 1993 Oct;122(4):388–394. [PubMed] [Google Scholar]
  3. Bird H. A., Le Gallez P., Dixon J. S., Catalano M. A., Traficante A., Liauw L. A., Sussman H., Rotman H., Wright V. A clinical and biochemical assessment of a nonthiol ACE inhibitor (pentopril; CGS-13945) in active rheumatoid arthritis. J Rheumatol. 1990 May;17(5):603–608. [PubMed] [Google Scholar]
  4. Cambridge H., Brain S. D. Kinin B2 and B1 receptor-mediated vasoactive effects in rabbit synovium. Peptides. 1998;19(3):569–576. doi: 10.1016/s0196-9781(97)00379-3. [DOI] [PubMed] [Google Scholar]
  5. Corbett J. A., Kwon G., Turk J., McDaniel M. L. IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry. 1993 Dec 21;32(50):13767–13770. doi: 10.1021/bi00213a002. [DOI] [PubMed] [Google Scholar]
  6. DUMONDE D. C., GLYNN L. E. The production of arthritis in rabbits by an immunological reaction to fibrin. Br J Exp Pathol. 1962 Aug;43:373–383. [PMC free article] [PubMed] [Google Scholar]
  7. Davidge S. T., Baker P. N., Laughlin M. K., Roberts J. M. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res. 1995 Aug;77(2):274–283. doi: 10.1161/01.res.77.2.274. [DOI] [PubMed] [Google Scholar]
  8. DeShazo C. V., Henson P. M., Cochrane C. G. Acute immunologic arthritis in rabbits. J Clin Invest. 1972 Jan;51(1):50–57. doi: 10.1172/JCI106796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Grabowski P. S., Macpherson H., Ralston S. H. Nitric oxide production in cells derived from the human joint. Br J Rheumatol. 1996 Mar;35(3):207–212. doi: 10.1093/rheumatology/35.3.207. [DOI] [PubMed] [Google Scholar]
  10. Ianaro A., O'Donnell C. A., Di Rosa M., Liew F. Y. A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology. 1994 Jul;82(3):370–375. [PMC free article] [PubMed] [Google Scholar]
  11. Inoue T., Fukuo K., Morimoto S., Koh E., Ogihara T. Nitric oxide mediates interleukin-1-induced prostaglandin E2 production by vascular smooth muscle cells. Biochem Biophys Res Commun. 1993 Jul 15;194(1):420–424. doi: 10.1006/bbrc.1993.1836. [DOI] [PubMed] [Google Scholar]
  12. Kaplan S. S., Billiar T., Curran R. D., Zdziarski U. E., Simmons R. L., Basford R. E. Inhibition of chemotaxis Ng-monomethyl-L-arginine: a role for cyclic GMP. Blood. 1989 Nov 1;74(6):1885–1887. [PubMed] [Google Scholar]
  13. Kelner M. J., Uglik S. F. Mechanism of prostaglandin E2 release and increase in PGH2/PGE2 isomerase activity by PDGF: involvement of nitric oxide. Arch Biochem Biophys. 1994 Jul;312(1):240–243. doi: 10.1006/abbi.1994.1305. [DOI] [PubMed] [Google Scholar]
  14. Kubes P., Suzuki M., Granger D. N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4651–4655. doi: 10.1073/pnas.88.11.4651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Manfield L., Jang D., Murrell G. A. Nitric oxide enhances cyclooxygenase activity in articular cartilage. Inflamm Res. 1996 May;45(5):254–258. doi: 10.1007/BF02259612. [DOI] [PubMed] [Google Scholar]
  16. Martin M. F., Surrall K. E., McKenna F., Dixon J. S., Bird H. A., Wright V. Captopril: a new treatment for rheumatoid arthritis? Lancet. 1984 Jun 16;1(8390):1325–1328. doi: 10.1016/s0140-6736(84)91821-x. [DOI] [PubMed] [Google Scholar]
  17. McCartney-Francis N., Allen J. B., Mizel D. E., Albina J. E., Xie Q. W., Nathan C. F., Wahl S. M. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med. 1993 Aug 1;178(2):749–754. doi: 10.1084/jem.178.2.749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Milano S., Arcoleo F., Dieli M., D'Agostino R., D'Agostino P., De Nucci G., Cillari E. Prostaglandin E2 regulates inducible nitric oxide synthase in the murine macrophage cell line J774. Prostaglandins. 1995 Feb;49(2):105–115. doi: 10.1016/0090-6980(94)00004-g. [DOI] [PubMed] [Google Scholar]
  19. Molina-Holgado F., Lledó A., Guaza C. Evidence for cyclooxygenase activation by nitric oxide in astrocytes. Glia. 1995 Oct;15(2):167–172. doi: 10.1002/glia.440150209. [DOI] [PubMed] [Google Scholar]
  20. Novaes G. S., Mello S. B., Laurindo I. M., Cossermelli W. Low dose methotrexate decreases intraarticular prostaglandin and interleukin 1 levels in antigen induced arthritis in rabbits. J Rheumatol. 1996 Dec;23(12):2092–2097. [PubMed] [Google Scholar]
  21. Novaes G. S., de Mello S. B., Laurindo I. M., Palacios F. A., Cossermelli W. Níveis intra-articulares de óxido nítrico em pacientes com doença reumatóide. Rev Hosp Clin Fac Med Sao Paulo. 1997 Mar-Apr;52(2):55–59. [PubMed] [Google Scholar]
  23. Palmer R. M., Hickery M. S., Charles I. G., Moncada S., Bayliss M. T. Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun. 1993 May 28;193(1):398–405. doi: 10.1006/bbrc.1993.1637. [DOI] [PubMed] [Google Scholar]
  24. Radomski M. W., Palmer R. M., Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A. 1990 Dec;87(24):10043–10047. doi: 10.1073/pnas.87.24.10043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Salmon J. A. A radioimmunoassay for 6-keto-prostaglandin F1alpha. Prostaglandins. 1978 Mar;15(3):383–397. doi: 10.1016/0090-6980(78)90122-3. [DOI] [PubMed] [Google Scholar]
  26. Salmon J. A., Simmons P. M., Palmer R. M. A radioimmunoassay for leukotriene B4. Prostaglandins. 1982 Aug;24(2):225–235. doi: 10.1016/0090-6980(82)90148-4. [DOI] [PubMed] [Google Scholar]
  27. Salvemini D., Misko T. P., Masferrer J. L., Seibert K., Currie M. G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7240–7244. doi: 10.1073/pnas.90.15.7240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Salvemini D., Seibert K., Masferrer J. L., Misko T. P., Currie M. G., Needleman P. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest. 1994 May;93(5):1940–1947. doi: 10.1172/JCI117185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Salvemini D., Settle S. L., Masferrer J. L., Seibert K., Currie M. G., Needleman P. Regulation of prostaglandin production by nitric oxide; an in vivo analysis. Br J Pharmacol. 1995 Mar;114(6):1171–1178. doi: 10.1111/j.1476-5381.1995.tb13330.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Samuelsson B., Dahlén S. E., Lindgren J. A., Rouzer C. A., Serhan C. N. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 1987 Sep 4;237(4819):1171–1176. doi: 10.1126/science.2820055. [DOI] [PubMed] [Google Scholar]
  31. St Clair E. W., Wilkinson W. E., Lang T., Sanders L., Misukonis M. A., Gilkeson G. S., Pisetsky D. S., Granger D. I., Weinberg J. B. Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. J Exp Med. 1996 Sep 1;184(3):1173–1178. doi: 10.1084/jem.184.3.1173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Stadler J., Harbrecht B. G., Di Silvio M., Curran R. D., Jordan M. L., Simmons R. L., Billiar T. R. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J Leukoc Biol. 1993 Feb;53(2):165–172. doi: 10.1002/jlb.53.2.165. [DOI] [PubMed] [Google Scholar]
  33. Stadler J., Stefanovic-Racic M., Billiar T. R., Curran R. D., McIntyre L. A., Georgescu H. I., Simmons R. L., Evans C. H. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol. 1991 Dec 1;147(11):3915–3920. [PubMed] [Google Scholar]
  34. Stefanovic-Racic M., Meyers K., Meschter C., Coffey J. W., Hoffman R. A., Evans C. H. Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. J Rheumatol. 1995 Oct;22(10):1922–1928. [PubMed] [Google Scholar]
  35. Stefanovic-Racic M., Meyers K., Meschter C., Coffey J. W., Hoffman R. A., Evans C. H. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum. 1994 Jul;37(7):1062–1069. doi: 10.1002/art.1780370712. [DOI] [PubMed] [Google Scholar]
  36. Stefanovic-Racic M., Stadler J., Georgescu H. I., Evans C. H. Nitric oxide and energy production in articular chondrocytes. J Cell Physiol. 1994 May;159(2):274–280. doi: 10.1002/jcp.1041590211. [DOI] [PubMed] [Google Scholar]
  37. Stefanovic-Racic M., Stadler J., Georgescu H. I., Evans C. H. Nitric oxide synthesis and its regulation by rabbit synoviocytes. J Rheumatol. 1994 Oct;21(10):1892–1898. [PubMed] [Google Scholar]
  38. Swierkosz T. A., Mitchell J. A., Warner T. D., Botting R. M., Vane J. R. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br J Pharmacol. 1995 Apr;114(7):1335–1342. doi: 10.1111/j.1476-5381.1995.tb13353.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Taskiran D., Stefanovic-Racic M., Georgescu H., Evans C. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Commun. 1994 Apr 15;200(1):142–148. doi: 10.1006/bbrc.1994.1426. [DOI] [PubMed] [Google Scholar]
  40. Tetsuka T., Daphna-Iken D., Srivastava S. K., Baier L. D., DuMaine J., Morrison A. R. Cross-talk between cyclooxygenase and nitric oxide pathways: prostaglandin E2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12168–12172. doi: 10.1073/pnas.91.25.12168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Weinberg J. B., Granger D. L., Pisetsky D. S., Seldin M. F., Misukonis M. A., Mason S. N., Pippen A. M., Ruiz P., Wood E. R., Gilkeson G. S. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med. 1994 Feb 1;179(2):651–660. doi: 10.1084/jem.179.2.651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. de Mello S. B., Novaes G. S., Laurindo I. M., Muscará M. N., Maciel F. M., Cossermelli W. Nitric oxide synthase inhibitor influences prostaglandin and interleukin-1 production in experimental arthritic joints. Inflamm Res. 1997 Feb;46(2):72–77. doi: 10.1007/s000110050086. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES